Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M34.0Revenue (TTM) $M76.9Net Margin (%)61.3Altman Z-Score-2.1
Enterprise Value $M-4.0EPS (TTM) $0.6Operating Margin %36.8Piotroski F-Score5
P/E(ttm)0.8Beneish M-Score8.5Pre-tax Margin (%)61.3Higher ROA y-yY
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio7.3Cash flow > EarningsN
Price/Sales0.55-y EBITDA Growth Rate %--Current Ratio7.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)73.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.5ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with THLD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
THLDFirst Eagle Investment 2015-12-31 Sold Out -0.01%$0.46 - $4.4
($2.95)
$ 0.48-84%Sold Out0
THLDFirst Eagle Investment 2015-09-30 Reduce-0.01%$3.62 - $5.11
($4.31)
$ 0.48-89%Reduce -60.65%500,000
THLDFirst Eagle Investment 2015-06-30 Reduce$3.49 - $4.51
($4.01)
$ 0.48-88%Reduce -9.60%1,270,768
THLDFirst Eagle Investment 2015-03-31 Add$3.33 - $4.61
($3.99)
$ 0.48-88%Add 2.06%1,405,768
THLDFirst Eagle Investment 2014-12-31 Add$2.7 - $3.56
($3.02)
$ 0.48-84%Add 26.17%1,377,448
THLDFirst Eagle Investment 2014-09-30 Add$3.75 - $5.03
($4.2)
$ 0.48-89%Add 36.46%1,091,700
THLDFirst Eagle Investment 2014-03-31 Add0.01%$4.34 - $5.72
($4.92)
$ 0.48-90%Add 250.00%700,000
THLDFirst Eagle Investment 2012-12-31 Buy $3.98 - $6.55
($4.67)
$ 0.48-90%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

THLD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


THLD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Fernandes Joel ASenior Vice President 2015-09-28Buy3,562$3.96-87.88view
JAEGER WILFRED EDirector 2015-02-18Buy25,000$3.75-87.2view
Davar NipunVice President 2014-10-13Buy3,000$2.99-83.95view
YOUNGER WILLIAM H JR10% Owner 2014-10-01Sell242,396$3.77-87.27view
WHITE JAMES N10% Owner 2014-10-01Sell239,538$3.77-87.27view
SWEET DAVID E10% Owner 2014-10-01Sell229,154$3.77-87.27view
Speiser Michael L10% Owner 2014-10-01Sell227,228$3.77-87.27view
SHEEHAN ANDREW T10% Owner 2014-10-01Sell230,352$3.77-87.27view
Pullara Samuel J III10% Owner 2014-10-01Sell226,657$3.77-87.27view
GAITHER JAMES C10% Owner 2014-10-01Sell231,287$3.77-87.27view

Press Releases about THLD :

Quarterly/Annual Reports about THLD:

News about THLD:

Articles On GuruFocus.com
Tuesday Pre-Market Insights: THLD, PLL, AOL, CALL May 12 2015 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 47,619 Shares Mar 15 2011 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 04 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 05 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2010 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 05 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 52,356 Shares Oct 06 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2009 
Threshold Pharmaceuticals Inc. (THLD) CEO Harold E Selick buys 20,000 Shares Jun 05 2009 
Threshold Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2009 

More From Other Websites
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 20 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 27 2016
Most Popular Healthcare Penny Stocks Among Hedge Funds Jun 09 2016
Threshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO Annual Meeting Jun 06 2016
Threshold Pharmaceuticals Highlights Multiple Presentations at the 2016 ASCO Annual Meeting Jun 06 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events Jun 06 2016
Threshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference Jun 01 2016
Threshold Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference Jun 01 2016
THRESHOLD PHARMACEUTICALS INC Financials May 14 2016
Threshold Pharmaceuticals posts 1Q loss May 05 2016
Threshold Pharmaceuticals posts 1Q loss May 05 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 05 2016
Threshold Pharmaceuticals Reports First Quarter Financial Results May 05 2016
Threshold Pharmaceuticals Reports First Quarter Financial Results May 05 2016
ETF’s with exposure to Threshold Pharmaceuticals, Inc. : April 29, 2016 Apr 29 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 22 2016
ETF’s with exposure to Threshold Pharmaceuticals, Inc. : March 28, 2016 Mar 28 2016
Threshold Pharmaceuticals Appoints Stew Kroll as Chief Operating Officer Mar 21 2016
Threshold (THLD): Evofosfamide May Be Effective in Some Pancreatic Cancer Patients Mar 18 2016
THRESHOLD PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other... Mar 17 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)